LifeMD to Participate in Mizuho Securities Healthcare Technology Conference 2026 and KeyBanc Capital Markets Healthcare Forum

Reuters03-04

LifeMD to Participate in Mizuho Securities Healthcare Technology Conference 2026 and KeyBanc Capital Markets Healthcare Forum

LifeMD Inc. will participate in the Mizuho Securities Healthcare Technology Conference 2026 on March 5, holding virtual one-on-one investor meetings throughout the day. Management will also attend the KeyBanc Capital Markets Healthcare Forum on March 17-18, including a virtual fireside chat on March 18 at 9:00 a.m. ET and a virtual panel, “The Outlook for the GLP-1 Market: New Injection Modalities vs. Orals,” at 12:00 p.m. ET, along with additional one-on-one virtual meetings. More information: https://www.globenewswire.com/Tracker?data=LqPQnuzJdLW9H3XjAwm3Kk35ueAdfSfztUmjQ8Q3JJC58FAS-H1Xie2PxGxXqAXWU2wadUX8zgPuizkYT6jsgg== and https://www.globenewswire.com/Tracker?data=LqPQnuzJdLW9H3XjAwm3Kk31yUGBY-2La4wRAVHLaVGRZM4SJVLCoFnB9DihGsMGXalPCa-AYrf7Ys8je8wpVQ==.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeMD Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603031605PRIMZONEFULLFEED9665176) on March 03, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2616372933?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 05:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616372933","market":"us","top_or_hot":-1,"title":"LifeMD to Participate in Mizuho Securities Healthcare Technology Conference 2026 and KeyBanc Capital Markets Healthcare Forum","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      LifeMD to Participate in Mizuho Securities Healthcare Technology Conference 2026 and KeyBanc Capital Markets Healthcare Forum\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/LFMD\">LifeMD Inc.</a> will participate in the Mizuho Securities Healthcare Technology Conference 2026 on March 5, holding virtual one-on-one investor meetings throughout the day. Management will also attend the KeyBanc Capital Markets Healthcare Forum on March 17-18, including a virtual fireside chat on March 18 at 9:00 a.m. ET and a virtual panel, “The Outlook for the GLP-1 Market: New Injection Modalities vs. Orals,” at 12:00 p.m. ET, along with additional one-on-one virtual meetings. More information: https://www.globenewswire.com/Tracker?data=LqPQnuzJdLW9H3XjAwm3Kk35ueAdfSfztUmjQ8Q3JJC58FAS-H1Xie2PxGxXqAXWU2wadUX8zgPuizkYT6jsgg== and https://www.globenewswire.com/Tracker?data=LqPQnuzJdLW9H3XjAwm3Kk31yUGBY-2La4wRAVHLaVGRZM4SJVLCoFnB9DihGsMGXalPCa-AYrf7Ys8je8wpVQ==.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/LFMDP\">LifeMD Inc.</a> published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603031605PRIMZONEFULLFEED9665176) on March 03, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LifeMD to Participate in Mizuho Securities Healthcare Technology Conference 2026 and KeyBanc Capital Markets Healthcare Forum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLifeMD to Participate in Mizuho Securities Healthcare Technology Conference 2026 and KeyBanc Capital Markets Healthcare Forum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-04 05:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      LifeMD to Participate in Mizuho Securities Healthcare Technology Conference 2026 and KeyBanc Capital Markets Healthcare Forum\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/LFMD\">LifeMD Inc.</a> will participate in the Mizuho Securities Healthcare Technology Conference 2026 on March 5, holding virtual one-on-one investor meetings throughout the day. Management will also attend the KeyBanc Capital Markets Healthcare Forum on March 17-18, including a virtual fireside chat on March 18 at 9:00 a.m. ET and a virtual panel, “The Outlook for the GLP-1 Market: New Injection Modalities vs. Orals,” at 12:00 p.m. ET, along with additional one-on-one virtual meetings. More information: https://www.globenewswire.com/Tracker?data=LqPQnuzJdLW9H3XjAwm3Kk35ueAdfSfztUmjQ8Q3JJC58FAS-H1Xie2PxGxXqAXWU2wadUX8zgPuizkYT6jsgg== and https://www.globenewswire.com/Tracker?data=LqPQnuzJdLW9H3XjAwm3Kk31yUGBY-2La4wRAVHLaVGRZM4SJVLCoFnB9DihGsMGXalPCa-AYrf7Ys8je8wpVQ==.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/LFMDP\">LifeMD Inc.</a> published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603031605PRIMZONEFULLFEED9665176) on March 03, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NDAQ","symbol_name":"纳斯达克OMX交易所","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL2WV7X5:1","article_id":"2616372933","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616372933","pubTimestamp":1772574865,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"LifeMD to Participate in Mizuho Securities Healthcare Technology Conference 2026 and KeyBanc Capital Markets Healthcare Forum","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NDAQ":"纳斯达克OMX交易所","BK4167":"医疗保健技术","LFMD":"LifeMD Inc.","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","LU0976567544.SGD":"FTIF - Templeton Global Income A Mdis SGD-H1","BK4588":"碎股","LU1267930227.SGD":"TEMPLETON GLOBAL BALANCED \"AS\" (SGD) ACC A","BK4112":"金融交易所和数据","BK4183":"个人用品","LU0128525689.USD":"TEMPLETON GLOBAL BALANCED \"A\"(USD) ACC","LU0211326755.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) ACC","BK4207":"综合性银行","BK4589":"SVB概念","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","BK4211":"区域性银行","LU0211326839.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) INC","LU0310800965.SGD":"FTIF - Templeton Global Balanced A Acc SGD","LU0052756011.USD":"TEMPLETON GLOBAL BALANCED \"A\" (USD) INC","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","LU0496365809.HKD":"TEMPLETON GLOBAL INCOME \"A\" (HKD) INC (Q)","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","BK4585":"ETF&股票定投概念","KEY":"KeyCorp","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H"},"translate_title":"LifeMD将参加瑞穗证券医疗保健技术会议2026和KeyBanc资本市场医疗保健论坛","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KEY":0.9,"LFMD":0.9,"NDAQ":0.9},"content_text":"LifeMD to Participate in Mizuho Securities Healthcare Technology Conference 2026 and KeyBanc Capital Markets Healthcare Forum\n    \n\nLifeMD Inc. will participate in the Mizuho Securities Healthcare Technology Conference 2026 on March 5, holding virtual one-on-one investor meetings throughout the day. Management will also attend the KeyBanc Capital Markets Healthcare Forum on March 17-18, including a virtual fireside chat on March 18 at 9:00 a.m. ET and a virtual panel, “The Outlook for the GLP-1 Market: New Injection Modalities vs. Orals,” at 12:00 p.m. ET, along with additional one-on-one virtual meetings. More information: https://www.globenewswire.com/Tracker?data=LqPQnuzJdLW9H3XjAwm3Kk35ueAdfSfztUmjQ8Q3JJC58FAS-H1Xie2PxGxXqAXWU2wadUX8zgPuizkYT6jsgg== and https://www.globenewswire.com/Tracker?data=LqPQnuzJdLW9H3XjAwm3Kk31yUGBY-2La4wRAVHLaVGRZM4SJVLCoFnB9DihGsMGXalPCa-AYrf7Ys8je8wpVQ==.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeMD Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603031605PRIMZONEFULLFEED9665176) on March 03, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2616372933","isCrawlerRequest":true}